• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 03/27/15

    • 30-Day SEC Yield1

      1.08%
    • Total Net Assets

      $342.0M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.42%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2015
  • Portfolio Composition (%)
    as of 03/27/15

    • % of Net Assets
    • Stocks

      99.92
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.08
  • Download All HoldingsAll Holdings (%) as of 03/27/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Novartis Ag
    NVS US
    321,352
    32,263,7419.43
    Johnson & Johnson
    JNJ US
    288,475
    28,945,5828.46
    Pfizer Inc
    PFE US
    674,160
    23,278,7456.81
    Novo Nordisk A/S
    NVO US
    356,219
    19,178,8315.61
    Sanofi
    SNY US
    349,243
    17,451,6735.10
    Actavis Plc
    ACT US
    55,964
    16,988,4324.97
    Glaxosmithkline Plc
    GSK US
    359,192
    16,889,2084.94
    Merck & Co Inc
    MRK US
    292,363
    16,883,9634.94
    Astrazeneca Plc
    AZN US
    228,906
    16,039,4434.69
    Eli Lilly & Co
    LLY US
    215,464
    15,853,8414.64
    Valeant Pharmaceuticals International I
    VRX US
    76,146
    15,064,7254.40
    Abbvie Inc
    ABBV US
    260,521
    15,019,0364.39
    Abbott Laboratories
    ABT US
    318,596
    14,903,9214.36
    Bristol-Myers Squibb Co
    BMY US
    224,859
    14,674,2984.29
    Teva Pharmaceutical Industries Ltd
    TEVA US
    230,749
    14,301,8234.18
    Shire Plc
    SHPG US
    55,852
    13,458,6563.94
    Mckesson Corp
    MCK US
    55,462
    12,540,5133.67
    Mylan Inc/Pa
    MYL US
    116,339
    7,169,9732.10
    Perrigo Co
    PRGO US
    39,974
    6,634,4851.94
    Amerisourcebergen Corp
    ABC US
    58,047
    6,570,3401.92
    Zoetis Inc
    ZTS US
    119,288
    5,513,4911.61
    Mallinckrodt Plc
    MNK US
    27,367
    3,547,0371.04
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    38,233
    3,442,4991.01
    Hospira Inc
    HSP US
    31,823
    2,796,6050.82
    Salix Pharmaceuticals Ltd
    SLXP US
    13,416
    2,315,6020.68
    Other/Cash
    280,1260.08
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.